Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The 2.5 mg starting dose exists purely for gastrointestinal tolerance, not for metabolic effect
Studies began to unveil its efficacy in promoting healing and tissue repair in various other systems of the body, including musculoskeletal, cardiovascular, and nervous systems
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
FDA identified possible immunogenicity risks from aggregation and peptide-related impurities and proposed not adding either defined TB-500 substance to the 503A Bulks List
the focus will be different, so these effects might not be as potent (or immediate), but they still may occur
US$ 25.77
US$ 27.87
US$ 29.63
US$ 20.55